XML 37 R19.htm IDEA: XBRL DOCUMENT v3.8.0.1
Income Taxes
12 Months Ended
Dec. 31, 2017
Income Tax Disclosure [Abstract]  
Income Taxes
Income Taxes
Aspen Holdings and Aspen Bermuda are incorporated under the laws of Bermuda. Under current Bermuda law, they are not taxed on any Bermudian income or capital gains and they have received an undertaking from the Bermudian Minister of Finance that, in the event of any Bermudian income or capital gains taxes being imposed, they will be exempt from those taxes until March 31, 2035. Under current Australian law, Aspen Bermuda is however subject to tax on reinsurance premium it receives from the Australian branch of Aspen U.K. and this is reflected in the tables below.
The Company’s U.S. operating companies were subject to a U.S. federal income tax rate of 34% prior to January 1, 2018. Effective January 1, 2018, following the enactment of the U.S. Tax Cuts and Jobs Act of 2017 on December 22, 2017, the Company’s U.S. operating companies will be subject to a U.S. federal income tax rate of 21%. The reduction in U.S. federal income tax has been reflected in measuring the Company’s deferred taxes.
The Company's U.K. operating companies are taxed at the U.K. corporate tax rate which reduced from 20% to 19% effective April 1, 2017. The U.K. corporate tax rate will be further decreased to 17% effective on April 1, 2020.The reduction in the U.K. corporate tax rate has been reflected in measuring the Company’s deferred taxes.
Total income tax (benefit)/expense for the twelve months ended December 31, 2017, 2016 and 2015 was allocated as follows:  
 
 
Twelve Months Ended December 31,
 
 
2017
 
2016
 
2015
 
 
($ in millions)
Income tax (benefit)/expense allocated to net income
 
$
(15.4
)
 
$
6.1

 
$
14.4

Income tax (benefit) allocated to other comprehensive income
 
(17.4
)
 
(1.7
)
 
(15.3
)
Income tax (benefit) allocated directly to shareholders’ equity
 

 
(1.0
)
 
(1.9
)
Total income tax (benefit)/expense
 
$
(32.8
)
 
$
3.4

 
$
(2.8
)

(Loss)/income from operations before income tax and income tax expense/(benefit) attributable to that income/(loss) for the twelve months ended December 31, 2017, 2016 and 2015 is provided in the tables below:
 
 
Twelve Months Ended December 31, 2017
 
 
(Loss)/income
before tax
 
Current
income tax
expense/(benefit)
 
Deferred
income tax
(benefit)/expense
 
Total
income tax
(benefit)/expense
 
 
($ in millions)
Bermuda (1)
 
$
(130.0
)
 
$
0.9

 
$

 
$
0.9

U.S.
 
(140.3
)
 

 
1.1

 
1.1

U.K.
 
15.3

 
14.1

 
(33.3
)
 
(19.2
)
Other (2)
 
(26.8
)
 
2.1

 
(0.3
)
 
1.8

Total
 
$
(281.8
)
 
$
17.1

 
$
(32.5
)
 
$
(15.4
)
 
 
 
 
 
Twelve Months Ended December 31, 2016
 
 
(Loss)/income
before tax
 
Current
income tax
(benefit)/expense
 
Deferred
income tax
expense
 
Total
income tax
expense 
 
 
($ in millions)
Bermuda
 
$
259.5

 
$

 
$

 
$

U.S.
 
(70.2
)
 

 
2.5

 
2.5

U.K.
 
43.7

 
(3.2
)
 
5.4

 
2.2

Other (2)
 
(23.5
)
 
1.1

 
0.3

 
1.4

Total
 
$
209.5

 
$
(2.1
)
 
$
8.2

 
$
6.1

 
 
 
 
 
 
 
 
 
 
 
Twelve Months Ended December 31, 2015
 
 
(Loss)/income
before tax
 
Current
income tax
expense
 
Deferred
income tax
(benefit)
 
Total
income tax
expense/(benefit)
 
 
($ in millions)
Bermuda (1)
 
$
283.9

 
$
1.4

 
$

 
$
1.4

U.S.
 
(32.7
)
 
1.6

 
(4.1
)
 
(2.5
)
U.K.
 
79.9

 
15.5

 
(4.2
)
 
11.3

Other (2)
 
6.4

 
4.8

 
(0.6
)
 
4.2

Total
 
$
337.5

 
$
23.3

 
$
(8.9
)
 
$
14.4


 ______________ 
(1) 
Under Australian law, Aspen Bermuda is subject to tax on reinsurance premium it receives from the Australian branch of Aspen U.K.
(2) 
Beginning from the twelve months ended December 31, 2017, the total income tax (benefit)/expense allocation table has been re-presented to show the branches of Aspen U.K. under the “Other” category with the exception of the U.S. branch which is reported under the “U.S.” category.

The tax rate in Bermuda, the Company’s country of domicile, is zero. Application of the statutory tax rate for operations in other jurisdictions produces a differential to the expected tax (benefit)/expense as shown in the table below.
The reconciliation between the income tax (benefit)/expense and the statutory rate for the Company for the twelve months ended December 31, 2017 is provided in the table below:
 
 
Twelve Months Ended December 31,
 
 
2017
 
2016
 
2015
Income Tax Reconciliation
 
($ in millions)
Expected tax (benefit)/expense
 
$

 
$

 
$

Overseas statutory tax rates differential
 
(41.5
)
 
(19.3
)
 
6.4

Prior year adjustments (1)
 
1.3

 
3.3

 
(4.5
)
Valuation allowance
 
(37.9
)
 
21.0

 
11.8

Impact of unrecognized tax benefits (2)
 
0.1

 
(1.9
)
 

Restricted foreign tax credits

 
1.6

 
1.9

 
0.6

Share-based payments
 
(0.9
)
 

 

Foreign exchange
 
(2.1
)
 
0.2

 
(0.4
)
Non-deductible expenses
 
0.4

 
0.8

 
1.7

Non-taxable items
 
(0.9
)
 
(0.9
)
 
(1.3
)
Impact of changes in statutory tax rates
 
64.5

 
1.0

 
0.1

Total income tax (benefit)/expense
 
$
(15.4
)
 
$
6.1

 
$
14.4

________________
(1)     The submission dates for filing income tax returns for the Company’s U.S. and U.K. operating subsidiaries are after the submission date of the Company’s Annual Report on Form 10-K (this “report”). Accordingly, the final tax liabilities may differ from the estimated tax expense included in this report and may result in prior year adjustments being reported. The prior period adjustments for the twelve months ended December 31, 2017, 2016 and 2015 predominantly relate to the determination of results under U.K. GAAP, upon which the U.K. tax returns are based. These items can only be reasonably determined on an accurate basis after this report has been filed.
(2)    For 2017, the $0.1 million charge relates to a $0.3 million credit following the conclusion of a tax examination in respect of tax deductions for certain expenses and accrued interest of $0.4 million in respect of the adjustment of equity reserves. For 2016, the $1.9 million credit relates to a $3.2 million credit following the conclusion of a tax examination in respect of tax deductions for certain interest payments and accrued interest of $1.3 million in respect of the adjustment to equity reserves. For 2015, there was $Nil impact.
Unrecognized tax benefits. As illustrated in the table below, unrecognized tax benefits totaled $11.2 million as at December 31, 2017 and relate to U.K. prior period tax positions for the year 2011. An unrecognized tax benefit of $0.3 million relating to tax deductions for certain expenses was released during the year ended December 31, 2017 following the completion of the U.K. tax authority review. If they are recognized, the unrecognized tax benefits would reduce the Company’s effective tax rate. It is possible that the unrecognized tax benefits could be eliminated following completion of tax examinations into these matters.
 
 
Twelve Months Ended December 31,
 
 
2017
 
2016
 
 
($ in millions)
Unrecognized tax benefits balance at January 1
 
$
10.5

 
$
29.2

Foreign exchange re-translation
 
$
1.0

 
(3.4
)
Settlement in respect of tax position of prior years
 
$
(0.3
)
 
(15.3
)
Unrecognized tax benefits balance at December 31
 
$
11.2

 
$
10.5


The Company accrues interest and penalties related to an underpayment of income taxes, if applicable, as income tax expenses. The Company does not believe it will be subject to any penalties in any open tax years and has not accrued any such amounts for the twelve months ended December 31, 2017 (December 31, 2016 — $Nil). During the year, interest of $0.4 million was accrued in respect of the adjustment to equity reserves (December 31, 2016$1.3 million). Cumulative interest accrued as at December 31, 2017 was $1.7 million (December 31, 2016$1.3 million)
Income tax returns that have been filed by the Company’s U.S. operating subsidiaries are subject to examination for 2014 and later tax years. The Company’s U.K. operating subsidiaries’ income tax returns are subject to examination for 2016 and later tax years. This is in addition to the U.K. tax returns against which tax benefits have not been recognized, as detailed above.
The tax effects of temporary differences and carryforwards that give rise to deferred tax assets and deferred tax liabilities are presented in the following table as at December 31, 2017 and 2016:
 
 
As at December 31,
 
 
2017
 
2016
 
 
($ in millions)
Deferred tax assets:
Share-based payments
 
$
4.0

 
$
5.6

Operating loss carryforwards
 
102.5

 
124.5

Loss reserves
 
4.3

 
7.8

Accrued expenses
 
7.9

 
14.4

Foreign tax credit carryforwards
 
4.0

 
2.5

Unearned premiums
 
11.8

 
20.0

Deferred policy acquisition costs
 
5.9

 
2.1

Office properties and equipment
 
8.0

 
5.6

Other temporary differences
 
2.9

 
3.8

Total gross deferred tax assets
 
151.3

 
186.3

Less valuation allowance
 
(104.8
)
 
(142.5
)
Net deferred tax assets
 
$
46.5

 
$
43.8

 
 
 
 
 
Deferred tax liabilities:
 
 

 
 

Equalization provision reserves
 
$

 
$
(23.0
)
Intangible assets (other)
 
(2.0
)
 
(2.8
)
Deferred policy acquisition costs
 
(14.5
)
 
(22.4
)
Other temporary differences
 
(1.7
)
 
(1.7
)
Total gross deferred tax (liabilities)
 
(18.2
)
 
(49.9
)
 
 
 
 
 
Net deferred tax asset/(liability)
 
$
28.3

 
$
(6.1
)

Deferred tax liabilities and assets represent the tax effect of temporary differences between the value of assets and liabilities for financial statement purposes and such values as measured by U.K. and U.S. tax laws and regulations. Deferred tax assets and liabilities from the same tax jurisdiction have been netted off resulting in assets and liabilities being recorded under the deferred taxation captions on the consolidated balance sheet.
In assessing the realizability of deferred tax assets, management considers whether it is more likely than not that some portion or all of the deferred tax assets will not be realized. The ultimate realization of deferred tax assets is dependent upon the generation of future taxable income during the periods in which those temporary differences and carryforwards become deductible or creditable. Management considers the scheduled reversal of existing taxable temporary differences, projected future taxable income, and tax-planning strategies in making this assessment.
As at December 31, 2017, the Company had net operating losses carried forward for U.S. federal income tax purposes of $482.7 million (2016 — $343.2 million) and net operating losses carried forward for U.K. corporate tax purposes of $84.9 million (2016 — $18.2 million). The U.S. net operating losses are available to offset future U.S. federal taxable income, if any, with expiry periods between 2026 and 2036 and the U.K. net operating losses are available to offset future U.K. corporate income over an indefinite period. For U.S. federal income tax purposes, the Company also has capital loss carryforwards of $0.5 million (2016 — $0.5 million) with expiry periods between 2020 and 2022, and charitable contribution carryforwards of $0.7 million (2016 — $0.5 million) with expiry periods between 2018 and 2022. For U.K. corporate tax purposes, the Company has capital loss carryforwards of $3.8 million which is available to offset future U.K. capital gains over an indefinite period.
A full valuation allowance of $101.1 million (2016$139.2 million) on U.S. deferred tax assets (which includes these loss carryforwards) has been recognized at December 31, 2017 as management believes that it is more likely than not that a tax benefit will not be realized. The decrease in this portion of the valuation allowance totals $38.4 million (2016$20.7 million increase) with $38.4 million (2016$21.0 million increase) recorded in the consolidated income statement $Nil (2016$0.3 million decrease) recorded in other comprehensive income.
A valuation allowance of $3.7 million (2016 — $3.3 million) has been established against U.K. deferred tax assets. The increase in this portion of the valuation allowance totals $0.4 million (2016 — $2.6 million increase) with $0.4 million (2016 — $2.7 million increase) recorded in the consolidated income statement and $Nil (2016 — $Nil) recorded in other comprehensive income. The U.K. and U.S. valuation allowance combined total is $104.8 million (2016 — $142.5 million).
Included within the foreign tax credits totalling $4.0 million carried forward as at December 31, 2017, $1.2 million is due to expire in 2021. The remainder will continue to be available to carry forward indefinitely.
Aspen U.K. business includes income connected with a U.S. trade or business and therefore Aspen U.K has a branch for U.S. tax purposes (“U.S. Branch”). The U.S. Branch could become subject to an additional branch profits tax if earnings are repatriated to the Aspen U.K. head office or upon termination of the U.S. branch. However, based on the plans currently in place, the U.S. Branch profits are being, and Aspen U.K. intends they will continue to be, indefinitely reinvested in the U.S. Branch such that there is no branch profits tax liability arising in the current period or in the foreseeable future. Furthermore, based on the cumulative earnings position as at December 31, 2017, $Nil (2016$1.9 million) branch profits tax liability would be expected to arise. Accordingly, the Company has determined that no deferred tax liability for branch profits tax has been recognized as permitted by ASC 740.